UPDATE 1-Glaxo buys protein-drinks firm Maxinutrition

LONDON, Dec 13 (Reuters) - GlaxoSmithKline said on Monday it had agreed to buy protein drinks firm Maxinutrition for 162 million pounds ($256 million) from its private-equity owners to complement its Lucozade sports drinks franchise.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.